Lithium Carbonate Tablet, Extended Release
Product Images NDC 0054-0020

1 FDA label image from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lithium Carbonate (NDC 0054-0020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fpl-bl-450mg-100tabs-04.jpg (Fpl Bl 450mg 100tabs 04)

Fpl-bl-450mg-100tabs-04.jpg (Fpl Bl 450mg 100tabs 04)
Lithium Carbonate Extended-release Tablets USP 450 mg oral dosage form label shows a bottle containing 100 tablets. The label includes storage instructions, warnings to see package insert, and child-resistant container advice. The labeler is West-Ward Pharmaceuticals Corp., Eatonstown, NJ. A barcode and NDC 0054-0020-25 are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.